276 related articles for article (PubMed ID: 16168725)
1. Adhesion molecules in inflammatory bowel disease: therapeutic implications for gut inflammation.
Danese S; Semeraro S; Marini M; Roberto I; Armuzzi A; Papa A; Gasbarrini A
Dig Liver Dis; 2005 Nov; 37(11):811-8. PubMed ID: 16168725
[TBL] [Abstract][Full Text] [Related]
2. [Adhesion molecules: their role in physiopathology and treatment of inflammatory bowel disease].
Panés J
Gastroenterol Hepatol; 1999 Dec; 22(10):514-24. PubMed ID: 10650667
[No Abstract] [Full Text] [Related]
3. Anti-adhesion molecule therapies in inflammatory bowel disease: touch and go.
Stefanelli T; Malesci A; De La Rue SA; Danese S
Autoimmun Rev; 2008 May; 7(5):364-9. PubMed ID: 18486923
[TBL] [Abstract][Full Text] [Related]
4. Physiological basis for novel drug therapies used to treat the inflammatory bowel diseases. I. Immunology and therapeutic potential of antiadhesion molecule therapy in inflammatory bowel disease.
Van Assche G; Rutgeerts P
Am J Physiol Gastrointest Liver Physiol; 2005 Feb; 288(2):G169-74. PubMed ID: 15647604
[TBL] [Abstract][Full Text] [Related]
5. Selectins and integrins but not platelet-endothelial cell adhesion molecule-1 regulate opioid inhibition of inflammatory pain.
Machelska H; Brack A; Mousa SA; Schopohl JK; Rittner HL; Schäfer M; Stein C
Br J Pharmacol; 2004 Jun; 142(4):772-80. PubMed ID: 15159283
[TBL] [Abstract][Full Text] [Related]
6. The intestinal microvasculature as a therapeutic target in inflammatory bowel disease.
Hatoum OA; Heidemann J; Binion DG
Ann N Y Acad Sci; 2006 Aug; 1072():78-97. PubMed ID: 17057192
[TBL] [Abstract][Full Text] [Related]
7. Novel approaches to treating inflammatory bowel disease: targeting alpha-4 integrin.
Sandborn WJ; Yednock TA
Am J Gastroenterol; 2003 Nov; 98(11):2372-82. PubMed ID: 14638336
[TBL] [Abstract][Full Text] [Related]
8. MAdCAM-1 expressed in chronic inflammatory liver disease supports mucosal lymphocyte adhesion to hepatic endothelium (MAdCAM-1 in chronic inflammatory liver disease).
Grant AJ; Lalor PF; Hübscher SG; Briskin M; Adams DH
Hepatology; 2001 May; 33(5):1065-72. PubMed ID: 11343233
[TBL] [Abstract][Full Text] [Related]
9. Amelioration of murine experimental colitis by inhibition of mucosal addressin cell adhesion molecule-1.
Kato S; Hokari R; Matsuzaki K; Iwai A; Kawaguchi A; Nagao S; Miyahara T; Itoh K; Ishii H; Miura S
J Pharmacol Exp Ther; 2000 Oct; 295(1):183-9. PubMed ID: 10991977
[TBL] [Abstract][Full Text] [Related]
10. Targeting leukocyte integrins in human diseases.
Yonekawa K; Harlan JM
J Leukoc Biol; 2005 Feb; 77(2):129-40. PubMed ID: 15548573
[TBL] [Abstract][Full Text] [Related]
11. Physiology and pathophysiology of selectins, integrins, and IgSF cell adhesion molecules focusing on inflammation. A paradigm model on infectious endocarditis.
Golias C; Batistatou A; Bablekos G; Charalabopoulos A; Peschos D; Mitsopoulos P; Charalabopoulos K
Cell Commun Adhes; 2011 Jun; 18(3):19-32. PubMed ID: 21892874
[TBL] [Abstract][Full Text] [Related]
12. [Regulation of leukocyte migration by adhesion molecules].
Spertini O
Schweiz Med Wochenschr; 1996 Nov; 126(45):1926-34. PubMed ID: 8992620
[TBL] [Abstract][Full Text] [Related]
13. Elmer's glue, Elsie and you: clinical applications of adhesion molecules.
Schnapp LM
Mt Sinai J Med; 1998 May; 65(3):224-31. PubMed ID: 9615575
[TBL] [Abstract][Full Text] [Related]
14. Endothelial adhesion molecules in health and disease.
Cotran RS; Mayadas-Norton T
Pathol Biol (Paris); 1998 Mar; 46(3):164-70. PubMed ID: 9769911
[TBL] [Abstract][Full Text] [Related]
15. VEGF-A links angiogenesis and inflammation in inflammatory bowel disease pathogenesis.
Scaldaferri F; Vetrano S; Sans M; Arena V; Straface G; Stigliano E; Repici A; Sturm A; Malesci A; Panes J; Yla-Herttuala S; Fiocchi C; Danese S
Gastroenterology; 2009 Feb; 136(2):585-95.e5. PubMed ID: 19013462
[TBL] [Abstract][Full Text] [Related]
16. Pathogenic angiogenesis in IBD and experimental colitis: new ideas and therapeutic avenues.
Chidlow JH; Shukla D; Grisham MB; Kevil CG
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G5-G18. PubMed ID: 17463183
[TBL] [Abstract][Full Text] [Related]
17. In situ expression of the cell adhesion molecules in inflammatory bowel disease. Evidence of immunologic activation of vascular endothelial cells.
Nakamura S; Ohtani H; Watanabe Y; Fukushima K; Matsumoto T; Kitano A; Kobayashi K; Nagura H
Lab Invest; 1993 Jul; 69(1):77-85. PubMed ID: 7687311
[TBL] [Abstract][Full Text] [Related]
18. Monoclonal antibodies specific for beta 7 integrin and mucosal addressin cell adhesion molecule-1 (MAdCAM-1) reduce inflammation in the colon of scid mice reconstituted with CD45RBhigh CD4+ T cells.
Picarella D; Hurlbut P; Rottman J; Shi X; Butcher E; Ringler DJ
J Immunol; 1997 Mar; 158(5):2099-106. PubMed ID: 9036954
[TBL] [Abstract][Full Text] [Related]
19. Homocysteine triggers mucosal microvascular activation in inflammatory bowel disease.
Danese S; Sgambato A; Papa A; Scaldaferri F; Pola R; Sans M; Lovecchio M; Gasbarrini G; Cittadini A; Gasbarrini A
Am J Gastroenterol; 2005 Apr; 100(4):886-95. PubMed ID: 15784037
[TBL] [Abstract][Full Text] [Related]
20. Crucial role of the protein C pathway in governing microvascular inflammation in inflammatory bowel disease.
Scaldaferri F; Sans M; Vetrano S; Graziani C; De Cristofaro R; Gerlitz B; Repici A; Arena V; Malesci A; Panes J; Grinnell BW; Danese S
J Clin Invest; 2007 Jul; 117(7):1951-60. PubMed ID: 17557119
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
